ArticleBMC health services research2026
Beyond free healthcare: household out-of-pocket expenditure and catastrophic health expenditure among chronic kidney disease patients attending a tertiary care hospital in Sri Lanka.
Article in BMC health services research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChronic kidney disease (CKD) is a major global public health challenge associated with high morbidity, premature mortality, and substantial healthcare costs. In Sri Lanka, CKD is a public health priority due to the high prevalence of diabetes, hypertension, and chronic kidney disease of unknown etiology (CKDu). Although public healthcare services are largely free at the point of delivery, CKD imposes considerable financial pressure on households through out-of-pocket expenditure (OOPE). This study assessed the household economic burden among CKD patients attending a tertiary care hospital in Sri Lanka, measured through OOPE and catastrophic health expenditure (CHE).
methodsAn analytical cross-sectional study was conducted from May to June 2019 among patients with CKD attending the renal clinic, ward, and hemodialysis unit of a government tertiary hospital. OOPE was assessed through direct patient interviews using a structured questionnaire developed for this study, capturing direct medical, non-medical, and indirect costs. CHE was defined as OOPE exceeding ≥ 25% and ≥ 40% of total monthly household income, reflecting different levels of financial burden. Costs were collected in Sri Lankan Rupees (LKR) and converted to United States Dollars (USD) using the 2019 average exchange rate (1 USD = 178.8 LKR). Associations between CHE and selected variables were examined using multivariable binary logistic regression.
resultsA total of 272 participants were included (response rate 90.7%). Median monthly OOPE was highest for hemodialysis care (LKR 38,540 [USD 215]), followed by inpatient care (LKR 16,000 [USD 89]) and clinic care (LKR 4,050 [USD 23]). Direct non-medical costs contributed substantially in all three patient groups. At the 25% threshold, CHE occurred in 74.0% (95% CI: 64.3-82.3) of hemodialysis patients, 51.3% (95% CI: 39.7-62.8) of inpatients, and 9.6% (95% CI: 4.5-17.4) of clinic patients; overall CHE was 45.2% (95% CI: 39.2-51.3). At the 40% threshold, overall CHE was 35.7% (95% CI: 30.0-41.7). Higher age and higher income were associated with lower odds of CHE.
conclusionsCKD imposes a substantial economic burden on households in Sri Lanka, particularly among patients receiving hemodialysis and inpatient care. Financial protection strategies should address major non-medical costs, including transport and dietary expenses, while strengthening existing social assistance programs for vulnerable households.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.